Bionano Genomics (BNGO) Short term Debt (2017 - 2023)

Bionano Genomics (BNGO) has 5 years of Short term Debt data on file, last reported at $10.0 million in Q3 2023.

• For the quarter ending Q3 2023, Short term Debt rose 7.49% year-over-year to $10.0 million; the trailing twelve-month figure through Sep 2023 stood at $10.0 million (up 7.49% YoY), and the FY2022 full-year result was $9.4 million, changed N/A from the prior year.
• Short term Debt held at $10.0 million in Q3 2023, from $10.0 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $20.1 million in Q4 2019 to a low of $799815.0 in Q2 2019.
• A 4-year average of $10.4 million and a median of $9.7 million in 2023 frame the typical range for Short term Debt.
• Across the five-year window, Short term Debt surged 1642.65% in 2020 and climbed 7.49% in 2023, its largest moves.
• Tracing BNGO's Short term Debt over 4 years: stood at $20.1 million in 2019, then decreased by 29.11% to $14.2 million in 2020, then sank by 34.11% to $9.4 million in 2022, then climbed by 6.59% to $10.0 million in 2023.
• Business Quant data shows BNGO's Short term Debt at $10.0 million in Q3 2023, $10.0 million in Q2 2023, and $9.5 million in Q1 2023.